Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients

BACKGROUND: PALB2, a gene in the homologous recombination repair (HRR) pathway of the DNA damage response (DDR), is associated with the efficacy of platinum-based chemotherapy, immunotherapy, and PARP inhibitor therapy in several tumors. However, the PALB2 characteristics, its correlation with immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiexia, Tang, Shuangfeng, Zhang, Chunning, Li, Mingyao, Zheng, Yating, Hu, Xue, Huang, Mengli, Cheng, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787147/
https://www.ncbi.nlm.nih.gov/pubmed/35087742
http://dx.doi.org/10.3389/fonc.2021.742833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787147/
https://www.ncbi.nlm.nih.gov/pubmed/35087742
http://dx.doi.org/10.3389/fonc.2021.742833

Ejemplares similares